685896-46-2Relevant academic research and scientific papers
PYRROLIDIN-2-ON DERIVATIVES AS EP4 RECEPTOR AGONISTS
-
Page 28, (2010/02/06)
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors having structural formula (I), their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
